Top headlines in AMD/Retina: Future of AMD epidemic; COVID-19 and the eye; and more
Click Here to Manage Email Alerts
This week, a speaker predicts the AMD epidemic will continue to challenge ophthalmologists; pegcetacoplan results in 18-month reduction in GA lesion growth; interim trial results show efficacy of photobiomodulation in dry AMD; and more.
Read the full coverage here:
AMD epidemic will continue to challenge ophthalmologists
Reduction in GA lesion growth continues at 18 months with pegcetacoplan
Interim trial results show efficacy of photobiomodulation in dry AMD
Ophthalmological manifestations observed in one-third of COVID-19 cases at single center
PDT may be effective for choroidal metastasis treatment
References:
Chew EY. Irving H. Leopold Lecture: Age-related macular degeneration: What have we learned from the age-related eye disease study (AREDS) and AREDS2? Presented at: Wills Eye Conference; March 10-12, 2022; Philadelphia.
Romero-Castro RM, et al. Retina. 2022;doi:10.1097/IAE.0000000000003457.
Sacconi R, et al. Retina. 2022;doi:10.1097/IAE.0000000000003305.
Collapse
Click Here to Manage Email Alerts
